Is this you? Create Your Porfile
Avatar

Coffey David Scott

Eli Lilly and Company

Publication

Featured researches published by Coffey David Scott.

Archive | 2016

NOVEL CRYSTALLINE FORMS OF -(2-CHLOROPHENYL)-METHANONE

Borghese Alfio; Coffey David Scott; Footman Pamela Kaye; Pedersen Steven Wayne; Reutzel-Edens Susan Marie; Tameze Shella Lenyonga; Timpe Carsten; Weber Carsten

Archive | 2015

ΝΕΕΣ ΚΡΥΣΤΑΛΛΙΚΕΣ ΜΟΡΦΕΣ {2-[1-(3,5-ΔΙΣ-ΤΡΙΦΘΟΡΟΜΕΘΥΛ-ΒΕΝΖΥΛ)-5-ΠΥΡΙΔΙΝ-4-ΥΛ-1Η-[1,2,3]ΤΡΙΑΖΟΛ-4-ΥΛ]- ΠΥΡΙΔΙΝ-3-ΥΛ}-(2-ΧΛΩΡΟΦΑΙΝΥΛ)-ΜΕΘΑΝΟΝΗΣ

Borghese Alfio; Coffey David Scott; Footman Pamela Kaye; Pedersen Steven Wayne; Reutzel-Edens Susan Marie; Tameze Shella Lenyonga; Weber Carsten; Timpe Carsten

Archive | 2014

Nye krystallinske former av {2-[1-(3,5-bistrifluormetylbenzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-klorfenyl)-metanon, fremgangsmåter for fremstilling derav, og farmasøytiske sammensetninger som inneholder slike.

Reutzel-Edens Susan Marie; Coffey David Scott; Pedersen Steven Wayne; Footman Pamela Kaye; Borghese Alfio; Tameze Shella Lenyonga; Weber Carsten

Archive | 2012

ΑΓΩΝΙΣΤΕΣ ΑΛΦΑ ΥΠΟΔΟΧΕΑ ΕΝΕΡΓΟΠΟΙΟΥΜΕΝΟΥ ΑΠΟ ΠΟΛΛΑΠΛΑΣΙΑΣΤΕΣ ΥΠΕΡΟΞΥΣΩΜΑΤΩΝ

Mantlo Nathan Bryan; Collado Ivan; Dominianni Samuel James; Etgen Garret Jay Junior; Garcia-Paredes Cristina; Johnston Richard Duane; Letourneau Michael Edward; Martinelli Michael John; Mayhugh Daniel Ray; Saeed Ashraf; Thompson Richard Craig; Wang Xiadong; Coffey David Scott; Schmid Christopher Randall; Vicenzi Jeffrey Thomas; Xu Yanping

Archive | 2010

NEUE KRISTALLINE FORMEN VON ä2-Ä1-(3,5-BISTRIFLUORMETHYLBENZYL)-5-PYRIDIN-4-YL-1H-Ä1,2,3ÜÜTRIAZOL-4-YLÜ-PYRIDIN-3-YLü-(2-CHLORPHENYL)METHANON

Borghese Alfio; Coffey David Scott; Footman Pamela Kaye; Pedersen Steven Wayne; Reutzel-Edens Susan Marie; Tameze Shella Lenyonga; Weber Carsten; Timpe Carsten

Archive | 2010

NUEVAS FORMAS CRISTALINAS (2-(1-(3,5-BIS-TRIFLUOROMETILBENCIL)-5-PIRIDIN-4-IL-1H-(1,2,3)TRIAZOL-4-IL)-PIRIDIN-3-IL)-(2-CLOROFENIL)-METADONA.

Borghese Alfio; Coffey David Scott; Footman Pamela Kaye; Pedersen Steven Wayne; Reutzel-Edens Susan Marie; Tameze Shella Lenyonga

Archive | 2010

Nye krystallinske former af {2-[1-(3,5-bis-trifluormethylbenzyl)-5-pyridin-4-YL-1H-[1,2,3]triazol-4-YL]-pyridin-3-YL}-(2-chlorphenyl)-methanon

Footman Pamela Kaye; Pedersen Steven Wayne; Reutzel-Edens Susan Marie; Tameze Shella Lenyonga; Weber Carsten; Timpe Carsten; Coffey David Scott; Borghese Alfio

Archive | 2008

Peroxisomproliferatoraktiveret receptor a agonister

Etgen Garret Jay Junior; Martinelli Michael John; Saeed Ashraf; Wang Xiadong; Coffey David Scott; Xu Yanping; Mantlo Nathan Bryan; Collado Ivan; Dominianni Samuel James; Garcia-Paredes Cristina; Johnston Richard Duane; Letourneau Michael Edward; Mayhugh Daniel Ray; Thompson Richard Craig; Schmid Christopher Randall; Vicenzi Jeffrey Thomas

Archive | 2008

PEROXISOM PROLIFERATOR AKTIVIERTEN REZEPTOR ALPHA AGONISTEN

Mantlo Nathan Bryan; Collado Ivan; Dominianni Samuel James; Etgen Garret Jay; Garcia-Paredes Cristina; Johnston Richard Duane; Letourneau Michael Edward; Martinelli Michael John; Mayhugh Daniel Ray; Saeed Ashraf; Thompson Richard Craig; Wang Xiadong; Coffey David Scott; Schmid Christopher Randall; Vicenzi Jeffrey Thomas; Xu Yanping

Archive | 2006

forma cristalina, composto, processo para preparar os mesmos, métodos para tratar uma condição associada com excesso de taquicininas, uso do composto cristalino, e, composição farmacêutica

Borghese Alfio; Coffey David Scott; Footman Pamela Kaye; Pedersen Steven Wayne; Reutzel-Edens Susan Marie; Tameze Sheila Lenyonga; Weber Carsten; Timpe Carsten

Researchain Logo
Decentralizing Knowledge